Related Experiment Video
Updated: Sep 2, 2025

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.8K
Hepatitis E update
1Department of Gastroenterology, Ege University Faculty of Medicine, Izmir, Turkey.
Hepatology Forum
|August 11, 2022
Summary
Hepatitis E virus (HEV) infection is a common cause of acute hepatitis globally. Testing for HEV is recommended for patients with hepatitis symptoms, as it is increasingly recognized as an endemic zoonotic infection in developed countries.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide.
- Historically, HEV was associated with developing countries and travelers, but is now recognized as endemic in high-income nations.
- HEV is primarily a zoonotic infection, posing a growing public health concern.
Purpose of the Study:
- To highlight the increasing prevalence of Hepatitis E virus (HEV) in developed countries.
- To emphasize the importance of HEV testing in patients presenting with acute hepatitis symptoms.
- To inform about specific risk groups and prevention strategies for HEV infection.
Main Methods:
- Review of current epidemiological data on HEV prevalence.
- Analysis of clinical presentations and risk factors associated with HEV infection.
- Consultation of guidelines from organizations like the European Association for the Study of the Liver.
Main Results:
- HEV is a common cause of acute hepatitis globally and is endemic in most high-income countries.
- HEV is largely a zoonotic infection, with genotype 3 prevalent in developed regions.
- Pregnant women (genotype 1) and individuals with chronic liver disease or older men (genotype 3) are at higher risk for severe outcomes.
Conclusions:
- Widespread testing for HEV is crucial for patients with acute hepatitis symptoms.
- Awareness of HEV as an endemic zoonotic infection in developed countries is necessary.
- Preventive measures, including safe water, proper meat handling, and caution in endemic areas, are vital to reduce HEV transmission.
Related Concept Videos
Diseases of the Liver and Gallbladder
916
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
916
Hepatic Portal System
1.8K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.8K
Hepatic Drug Excretion: Enterohepatic Cycling
1.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.7K

